These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8749022)

  • 1. Determination of apolipoprotein mRNA levels by ribonuclease protection assay.
    Mitchell A; Fidge N
    Methods Enzymol; 1996; 263():351-63. PubMed ID: 8749022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA quantitation by a simple and sensitive RNAse protection assay.
    Pape ME; Melchior GW; Marotti KR
    Genet Anal Tech Appl; 1991 Nov; 8(7):206-13. PubMed ID: 1772697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the HMG-CoA reductase inhibitor simvastatin and of cholestyramine on hepatic apolipoprotein mRNA levels in the rat.
    Mitchell A; Fidge N; Griffiths P
    Biochim Biophys Acta; 1993 Mar; 1167(1):9-14. PubMed ID: 8461338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A solution hybridization/RNase protection assay with riboprobes to determine absolute levels of apoB, A-I, and E mRNA in human hepatoma cell lines.
    Azrolan N; Breslow JL
    J Lipid Res; 1990 Jun; 31(6):1141-6. PubMed ID: 2165116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of LDL receptor, apolipoprotein B, apolipoprotein A-I and apolipoprotein A-IV mRNA in various mouse organs as determined by a novel RNA-excess solution hybridization assay.
    Srivastava RA; Pfleger BA; Schonfeld G
    Biochim Biophys Acta; 1991 Aug; 1090(1):95-101. PubMed ID: 1909181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein mRNA in liver and intestine of rats is affected by dietary beet fiber or cholestyramine.
    Sonoyama K; Nishikawa H; Kiriyama S; Niki R
    J Nutr; 1995 Jan; 125(1):13-9. PubMed ID: 7815170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 40 kilodalton rat liver nuclear protein binds specifically to apolipoprotein B mRNA around the RNA editing site.
    Lau PP; Chen SH; Wang JC; Chan L
    Nucleic Acids Res; 1990 Oct; 18(19):5817-21. PubMed ID: 2216773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA analysis by nuclease protection.
    Goldrick M; Kessler D
    Curr Protoc Neurosci; 2003 Aug; Chapter 5():Unit 5.1. PubMed ID: 18428580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo regulation of hepatic lipase activity and mRNA levels by diets which modify cholesterol influx to the liver.
    Benhizia F; Lagrange D; Malewiak MI; Griglio S
    Biochim Biophys Acta; 1994 Mar; 1211(2):181-8. PubMed ID: 8117745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonuclease protection assay on microchip electrophoresis.
    Yamaguchi Y; Yatsushiro S; Yamamura S; Abe H; Abe K; Watanabe M; Kajimoto K; Shinohara Y; Baba Y; Kataoka M
    Analyst; 2011 Jun; 136(11):2247-51. PubMed ID: 21509398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of internal controls to increase quantitative capabilities of the ribonuclease protection assay.
    Davis MJ; Bailey CS; Smith CK
    Biotechniques; 1997 Aug; 23(2):280-5. PubMed ID: 9266083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
    Staels B; Van Tol A; Fruchart JC; Auwerx J
    Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interfering with gene expression.
    Marx J
    Science; 2000 May; 288(5470):1370-2. PubMed ID: 10847851
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the interruption of enterohepatic circulation of bile acids by cholestyramine on apolipoprotein gene expression in the rat.
    Felgines C; Mazur A; Rayssiguier Y
    Life Sci; 1994; 55(13):1053-60. PubMed ID: 8084210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods for quantitation of radioactivity in protected hybrids in RNase protection assays.
    Pham K; LaForge KS; Kreek MJ
    Biotechniques; 1998 Aug; 25(2):198-200, 202, 204 passim. PubMed ID: 9714876
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
    Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNase protection assay for quantifying gene expression levels.
    Qu Y; Boutjdir M
    Methods Mol Biol; 2007; 366():145-58. PubMed ID: 17568123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin receptor messenger ribonucleic acid sequence alterations detected by ribonuclease cleavage in patients with syndromes of insulin resistance.
    Goldstein BJ; Kahn CR
    J Clin Endocrinol Metab; 1989 Jul; 69(1):15-24. PubMed ID: 2732294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of specific cDNA background synthesis introduced by reverse transcription in RT-PCR assays.
    Adrover MF; Muñoz MJ; Baez MV; Thomas J; Kornblihtt AR; Epstein AL; Jerusalinsky DA
    Biochimie; 2010 Dec; 92(12):1839-46. PubMed ID: 20709138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.